top of page


Episode 6 – Exploring FDA Final Guidance on PCCPs
Bridging Consulting releases Episode 6 of "Alexis and Ethan Explain It All," exploring FDA's final PCCP guidance for AI-enabled devices.
Yu Zhao
3 dic 20241 Min. de lectura
2 visualizaciones
0 comentarios


Bridging Consulting Launches Podcast Series on Digital Health and FDA Regulations
Bridging Consulting launches "Alexis and Ethan Explain It All" podcast, exploring FDA Digital Health, Generative AI, and healthcare innovati
Yu Zhao
3 nov 20241 Min. de lectura
3 visualizaciones
0 comentarios


Data-Driven Trends In Predetermined Change Control Plans
Data-driven trends show increased FDA authorization of PCCPs, enhancing SaMD compliance and postmarket change controls.
Yu Zhao
12 jul 20249 Min. de lectura
2 visualizaciones
0 comentarios


Yu Zhao Joins Orthogonal Panel on Accelerating AI Algorithm Updates with PCCP
Yu Zhao joined a panel hosted by Orthogonal discussing how PCCP accelerates AI algorithm updates, FDA policies, and best practices.
Yu Zhao
28 jun 20241 Min. de lectura
0 visualizaciones
0 comentarios


Part III: SaMD PCCP Implementation Beyond AIML: Considerations & Challenges
This article provides tips and practical considerations for PCCP implementation.
Yu Zhao
13 oct 20236 Min. de lectura
2 visualizaciones
0 comentarios


Part II: Deciphering New US Laws Around Predetermined Change Control Plan
This article deciphers the new U.S. laws around Predetermined Change Control Plans (PCCP).
Yu Zhao
10 oct 202311 Min. de lectura
1 visualización
0 comentarios


Part I: Medical Device Postmarket Change Controls and FDA 510(k) Software Modification Guidance
FDA's guidance on postmarket change controls for 510(k) software modifications ensures SaMD changes maintain safety and compliance.
Yu Zhao
4 oct 20235 Min. de lectura
4 visualizaciones
0 comentarios


Yu Zhao Co-Hosts Panel on Global AI-Based Medical Device Regulations at MedCon 2022
Yu Zhao co-hosted a panel on AI-based medical device regulations at MedCon 2022, discussing EU AI Act and U.S. FDA framework for SaMD.
Yu Zhao
3 may 20221 Min. de lectura
0 visualizaciones
0 comentarios
bottom of page